Published Date: Mon, Oct 26, 2026
Highmark will update its Medicare Part D formularies effective Jan. 1, 2027. These changes are designed to ensure your patients have continued access to affordable and effective prescription medications.
Some medications may be removed from the formularies or become subject to new restrictions. To identify if a drug's status or restriction has been updated, you will be able to review the 2027 formularies when they are made available on the Provider Resource Center’s (PRC's) Medicare Formularies page.
Effective Jan. 1, 2027, Highmark is replacing the Fundamental Formulary with the Performance Formulary. All plans using the Fundamental Formulary will be moved to the Performance Formulary.
Beginning in mid-November 2026, Highmark will send notification letters to both prescribing providers and affected members outlining specific changes to the Medicare Part D formularies.
If your patients are taking medications affected by these updates, you may consider the following options:
Coverage determination requests for the 2027 plan year can be submitted beginning Nov. 16. Highmark will review all requests and notify both you and the member of the decision. You may submit a coverage determination request via:
Note: West Virginia providers must use electronic submission pathways, as faxing of authorization forms is not permitted.
Quick Info
Never miss out on what matters. Subscribe to our emails and stay informed.